Human Acute Myeloid Leukemia Bone Marrow CD34+ Cells (Relapsed/Refractory)

Description

Human Acute Myeloid Leukemia CD34+ Cells are primary CD34+ hematopoietic cells isolated from bone marrow of adult patients with acute myeloid leukemia (AML). These cells are enriched for leukemic stem and progenitor populations and exhibit blast-like morphology with a high nuclear-to-cytoplasmic ratio. They express myeloid-associated markers including CD33, CD13, and CD117, and retain key biological characteristics of AML, making them suitable for studies of leukemic stem cell biology, protein expression in refractory AML CD34+ cells, bone marrow analysis of relapsed AML CD34+ cells, disease mechanisms, and therapeutic response. To ensure the quality of these primary cells, repeated freeze-thaw cycles are not recommended due to the fragile nature of these cells. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.